KLRA Insider Trading Activity and SEC Form 4 Filings
KLRA insider trading summary
Over the past 12 months, insiders at Kailera Therapeutics, Inc. (KLRA) reported 2 open-market purchases worth $16.0M by 2 insiders and no sales on SEC Form 4. Net insider buying was $16.0M.
Latest KLRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 20, 2026 | Rtw Investments, LP | Insider | Buy | $8.0M (500,000 @ $16.00) |
| Apr 20, 2026 | Roderick Wong | 10% Owner | Buy | $8.0M (500,000 @ $16.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.